Impact of novel oral anticoagulants vs warfarin on effusions after coronary artery bypass grafting.

Patients receiving NOACs after CABG are at increased risk of developing effusions requiring invasive interventions compared to patients receiving warfarin. This increased risk should be taken into consideration when choosing the appropriate anticoagulation strategy for postoperative patients with CABG.